The Federal Trade Commission (FTC) has filed a lawsuit against a California marketing company over charges that it deceptively advertised and sold a COVID-19 treatment plan to consumers.
Regulators accuse Golden Sunrise Nutraceutical, Inc. of falsely stating in advertising materials that its “Emergency D-Virus” treatment plan was approved by the FDA and scientifically proven to treat COVID-19. The agency says the defendants kept marketing the product in this way at a price point of $23,000 despite previous warnings.
“We warned the defendants not to falsely market their product as an effective treatment for COVID-19, but they didn’t stop. As this case makes clear, the FTC is prepared to sue companies that continue to make deceptive health claims about COVID-19 or other serious diseases,” said Andrew Smith, the FTC’s director of the Bureau of Consumer Protection. […]